Caitong International Asset Management’s Cabaletta Bio CABA Stock Holding History

Caitong International Asset Management’s Portfolio CABA Stock Details CABA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.77K	Sell	892 -430	-33%	-$1.41K	﹤0.01%	1364
2026 Q1	$3.56K	Buy	+1,322	New	+$3.67K	﹤0.01%	1165
2025 Q4	–	Sell	-8,983	Closed	-$21K	–	1928
2025 Q3	$21K	Buy	+8,983	New	+$15.4K	0.01%	679
2025 Q2	–	Sell	-1,409	Closed	-$1.95K	–	2035
2025 Q1	$1.95K	Buy	+1,409	New	+$3K	﹤0.01%	1360

Other funds holding CABA

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Caitong International Asset Management's CABA Position: Q2 2026 in Review

Caitong International Asset Management reduced its Cabaletta Bio (CABA) stake by 33% in Q2 2026, selling an estimated $1.41K and leaving 892 shares worth $2.77K. The position accounts for ﹤0.01% of the portfolio, ranked #1364.

Caitong International Asset Management first reported a position in CABA in Q1 2025 and has held it in 4 quarters since. The position peaked at $21K in Q3 2025. 139 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

Caitong International Asset Management held 892 shares of Cabaletta Bio worth $2.77K as of Q2 2026.
Caitong International Asset Management sold 430 Cabaletta Bio shares in Q2 2026, an estimated $1.41K.
Cabaletta Bio made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1364 holding.
Caitong International Asset Management first reported a position in Cabaletta Bio in Q1 2025 and has held it in 4 quarters since.
Caitong International Asset Management's Cabaletta Bio position peaked at $21K in Q3 2025.
139 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.